These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 22043749)
1. Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP). Wutthiworawong B; Thitiratsanont U; Saovaprut C; Subhangkasen I; Geyuraphun B; Ampornprut A; Phumongkutchai J; Tephusdinnaayuthaya S J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S15-21. PubMed ID: 22043749 [TBL] [Abstract][Full Text] [Related]
2. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Kim J; Kim SJ; Chang YS; Park WS Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity. Erol N; Gürsoy H; Sahin A; Basmak H J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371 [TBL] [Abstract][Full Text] [Related]
4. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity? Spandau U; Tomic Z; Ewald U; Larsson E; Akerblom H; Holmström G Acta Ophthalmol; 2013 Mar; 91(2):170-5. PubMed ID: 22268644 [TBL] [Abstract][Full Text] [Related]
5. Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity. Suk KK; Berrocal AM; Murray TG; Rich R; Major JC; Hess D; Johnson RA J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-4. PubMed ID: 21175113 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series. Dani C; Frosini S; Fortunato P; Bertini G; Pratesi S; Pollazzi L; Caputo R; La Torre A J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2194-7. PubMed ID: 22506618 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab injection in advanced retinopathy of prematurity. Choovuthayakorn J; Ubonrat K J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S70-5. PubMed ID: 22696855 [TBL] [Abstract][Full Text] [Related]
8. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis. Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024 [TBL] [Abstract][Full Text] [Related]
9. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan. Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192 [TBL] [Abstract][Full Text] [Related]
11. Diode laser photocoagulation for retinopathy of prematurity: outcomes after 7 years of treatment. Nicoara SD; Cristian C; Irimescu I; Stefanut AC; Zaharie G J Pediatr Ophthalmol Strabismus; 2014; 51(1):39-45. PubMed ID: 24256550 [TBL] [Abstract][Full Text] [Related]
12. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Chung EJ; Kim JH; Ahn HS; Koh HJ Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897 [TBL] [Abstract][Full Text] [Related]
13. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600 [TBL] [Abstract][Full Text] [Related]
14. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results]. Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158 [TBL] [Abstract][Full Text] [Related]
16. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin). Dorta P; Kychenthal A Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475 [TBL] [Abstract][Full Text] [Related]
17. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan. Wu WC; Kuo HK; Yeh PT; Yang CM; Lai CC; Chen SN Am J Ophthalmol; 2013 Jan; 155(1):150-158.e1. PubMed ID: 22967867 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Mintz-Hittner HA; Kuffel RR Retina; 2008 Jun; 28(6):831-8. PubMed ID: 18536599 [TBL] [Abstract][Full Text] [Related]
19. OUTCOMES OF NONCONFLUENT DIODE LASER PANRETINAL PHOTOCOAGULATION FOR AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB. Mammo DA; Rubino SM; Quiram PA Retina; 2021 Apr; 41(4):706-710. PubMed ID: 32796444 [TBL] [Abstract][Full Text] [Related]
20. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Kychenthal A; Dorta P Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]